APA (7th ed.) Citation

Ionin, V. A., Zaslavskaya, E. L., Barashkova, E. I., Pavlova, V. A., Borisov, G. I., Averchenko, K. A., . . . Schlyachto, E. V. Molecular mechanisms of left atrial fibrosis development in patients with atrial fibrillation and metabolic syndrome: What biomarkers should be used in clinical practice? «FIRMA «SILICEA» LLC.

Chicago Style (17th ed.) Citation

Ionin, V. A., E L. Zaslavskaya, E I. Barashkova, V A. Pavlova, G I. Borisov, K A. Averchenko, A N. Morozov, E I. Baranova, and E V. Schlyachto. Molecular Mechanisms of Left Atrial Fibrosis Development in Patients with Atrial Fibrillation and Metabolic Syndrome: What Biomarkers Should Be Used in Clinical Practice? «FIRMA «SILICEA» LLC.

MLA (9th ed.) Citation

Ionin, V. A., et al. Molecular Mechanisms of Left Atrial Fibrosis Development in Patients with Atrial Fibrillation and Metabolic Syndrome: What Biomarkers Should Be Used in Clinical Practice? «FIRMA «SILICEA» LLC.